Atossa Therapeutics Inc (ATOS) has gained Monday morning, with the stock climbing 2.19% in pre-market trading to 2.8. ATOS's short-term technical score of 33 indicates that the stock has traded less bullishly over the last month than 67% of stocks on the market. In the Biotechnology industry, which ranks 142 out of 146 industries, Atossa Therapeutics Inc ranks higher than 63% of stocks. Atossa Therapeutics Inc has fallen 13.84% over the past month, closing at $3.13 on October 11. During this period of time, the stock fell as low as $2.57 and as high as $3.22. ATOS has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
Atossa Therapeutics Inc has a Long-Term Technical rank of 19. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 81% of the market scoring higher. In the Biotechnology industry which is number 133 by this metric, ATOS ranks better than 45% of stocks.
Atossa Therapeutics Inc (ATOS) Up 2.19% in Premarket Trading
ATOS has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on ATOS!